Ocular Therapeutix Completes Proof Of Principle Study With Moxifloxacin-Loaded Punctum Plugs
Ocular Therapeutix, Inc. announced today the completion of a successful Proof of Principle clinical study with their novel sustained drug delivery moxifloxacin punctum plug.